logo

For the Inventor, By the Inventor

Rehovot, Israel

Eugene Varfolomeev

USPTO Granted Patents = 11

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 34(Granted Patents)


Company Filing History:

goldMedal11 out of 1,168 
 
Yeda Research and Develpment & Co. Ltd
 patents

Years Active: 1997-2008

Loading Chart...
11 patents (USPTO):Explore Patents
1. 7419804 - CASH (Caspase Homologue) with death effector domain, modulators of the function of FAS (2008-09-02),
2. 7407771 - Cash (caspase homologue) with death effector domain, modulators of the function of FAS receptors (2008-08-05),
3. 7323548 - Modulators of the function of FAS/APO1 receptors (2008-01-29),
4. 7186682 - Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors (2007-03-06),
5. 7108999 - Modulators of the function of FAS/AP01 receptors (2006-09-19),
6. 7101675 - Modulators of regulatory proteins (2006-09-05),
7. 6808891 - Modulators of the function of FAS/APO1 receptors (2004-10-26),
8. 6579697 - Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors (2003-06-17),
9. 6355780 - Antibodies to the death domain motifs of regulatory proteins (2002-03-12),
10. 5766917 - Method for identifying and producing a protease capable of cleaving the (1998-06-16),
11. 5665859 - Molecules influencing the shedding of the TNF receptor, their (1997-09-09),

Title: The Innovative Journey of Eugene Varfolomeev

Introduction

Eugene Varfolomeev, a prominent inventor based in Rehovot, Israel, has made significant contributions to the field of biomedicine. With an impressive portfolio of 11 patents, Varfolomeev's work has paved the way for advancements in understanding and manipulating cellular processes, particularly in apoptosis and immune response pathways.

Latest Patents

Among his latest innovations, Varfolomeev's patents include the development of CASH (Caspase Homologue) with a death effector domain. This invention focuses on proteins capable of modulating or mediating the function of MORT-1, which are crucial for regulating cell death. The patents also disclose DNA sequences encoding these proteins, their recombinant production methodologies, and potential applications in therapeutic contexts. Such groundbreaking work holds promise for developing novel treatments for diseases that involve dysregulation of apoptosis.

Career Highlights

Eugene Varfolomeev is associated with Yeda Research and Development Company Ltd., where he collaborates on advancing scientific research and commercialization of innovative technologies. His notable achievements in the field of patenting have established him as a key player in biotechnological advancements, particularly those pertaining to apoptosis and immune modulation.

Collaborations

Throughout his career, Varfolomeev has had the privilege of working alongside esteemed colleagues such as David Wallach and Mark Boldin. These collaborations have further enriched his research endeavors, leading to meaningful contributions in the scientific community, particularly in the areas of molecular biology and therapeutic development.

Conclusion

Eugene Varfolomeev's journey as an inventor illustrates the profound impact that innovative minds can have on science and medicine. His extensive patent portfolio and ongoing collaborative efforts underscore the importance of continued research and development in molecular biology, promising to advance our understanding of complex biological processes for therapeutic benefits.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…